eMedevents
  • 142,173+ Medical Conferences
  • 273 Specialties
  • 10,716 Organizers
  • 153,596 Speakers
  • 156 Countries
  • 4,630 Cities
47,391+
CME Conference Registrations Sold
Home  >  Conferences  >  12th International Congress on Myeloproliferative Neoplasms (MPN)
AMA PRA Category 1 : 10.75 | MOC : 10.75

12th International Congress on Myeloproliferative Neoplasms (MPN)

Oct 24 - 25, 2019   |   New York, New York  United States Of America
Specialties : Oncology   |   Hematology Blood and Marrow Transplant   |   Hematopathology   |   Internal Medicine   |   Haematology
Conference Brochure

12th International Congress on Myeloproliferative Neoplasms (MPNs) is organized by Melton Medical Education, LLC and will be held from Oct 24 - 25, 2019 at The Westin New York at Times Square, New York City, New York, United States of America.

Target Audience:
The 12th International Congress on MPNs is specifically designed for hematologists, medical oncologists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and chronic myeloid leukemia.

Accreditation:
The Medical Society of the State of New York designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Description:
Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders.

The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis, and management, as well as the roles of next-generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed

New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning.

Congress attendees will have the opportunity to participate in a variety of educational formats including didactic sessions, case reviews, poster sessions and oral abstract presentations, as well as multiple networking and one-on-one discussion opportunities. To allow more time for participant questions, time has also been allotted for a panel discussion with Congress faculty.

Educational Objectives:
After participating in this program, participants should be able to:
• Describe underlying molecular and genetic events involved in MPNs and how these events could be utilized in the clinic.
• Discuss the role and utilization of current approved therapies in MPNs, as well as the potential role of agents in development.
• Assess how to manage symptoms and therapy-associated adverse events for patients with MPNs.
• Outline the current treatment strategies (including treatment termination) for patients with chronic myeloid leukemia (CML).

Additional details will be posted as soon as they are available.

View All Speaking

Amy D. Klion
Amy D. Klion

Infectious Disease

View All Attending

Forouzan Bahmani
Forouzan Bahmani

Haematology

Hope Qamoos
Hope Qamoos

Nurse Practitioner

Julie M Wu
Julie M Wu

Oncology

Tracking

Michelle Smith
Michelle Smith

Music Therapy

James
James

Medical Oncology

Conference Details

Exhibit Details : View Exhibit

Registration Desk

Contact No. : (512) 619-5534
512-619-5534
Email:
Heather@meltonmeded.com
info@MeltonMedEd.com
Abstraction date:
September 12, 2019

View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

The Westin New York at Times Square
270 W 43rd St
New York, New York, United States Of America

Official Hotel

The Westin New York at Times Square,

270 W 43rd St,

New York City, New York, United States of America 10036,

+1 212-201-2700

Plan Your Travel

 
 
 
 

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

EVEN Hotel Brooklyn
4.84 miles from venue
Price : USD 177.00 Per Night
Hilton Brooklyn New York
4.71 miles from venue
Price : USD 145.00 Per Night
Sheraton Brooklyn New York
4.57 miles from venue
Price : USD 179.10 Per Night
The Justice Suites
4.54 miles from venue
Price : USD 135.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Description Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee
Close

Exhibit Details

Start Date End Date Exhibit Fee
24 Oct 07:30 AM 25 Oct 01:00 PM USD 6000.00